ABVC (ABVC BioPharma Inc) שולי רווח נקי ממכירות

ABVC BioPharma revenues are based on licenses and milestone payments for the development of biologics targeting oncology and depression. Management is currently adapting the product portfolio to meet market demand while anticipating investor support. Net marginal sales income demonstrates business efficiency, where the value of 0.00 serves as the current metric, and growth is accelerating through partnerships with Asian medical centers to implement plant extracts.
פילוחי נתונים אנליטיים מרוכזים עבור ABVC BioPharma, Inc (ABVC)

This indicator determines the share of net profit in every dollar of revenue, reflecting the overall efficiency of operating activities. For ABVC BioPharma (ABVC), this metric confirms the ability to monetize developments in oncology and neurology while accounting for R&D costs. The net profit margin trend allows for an assessment of the diversified portfolio's impact on profitability. The stability of this figure demonstrates the business model's resilience to market fluctuations, ensuring the long-term preservation and growth of invested capital.